1.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: Levosta-CBF-02/04, NCT00215007
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Over 16
Sponsor: Other
Protocol IDs: FRE-FNCLCC-GETUG-13/0206, EU-20502, NCT00104676
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 50
Sponsor: Other
Protocol IDs: BARTS-TE3, EU-20608, ISRCTN08648791, NCT00324298
|
|
4.
|
Phase: Phase III
Type: Diagnostic, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 55/05, ALLG SC01, NHMRC Project Grant 331305, NCT00163722
|
|
5.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 12 to 65
Sponsor: Other
Protocol IDs: PROGAST, NCT00180089
|
|
6.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 75
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: FHCRC-1825.00, 5605, SUPERGEN-FHCRC-1825.00, NCT00096161
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-06077, NCT00423852
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2005-0445, NCT00492817
|
|
9.
|
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 to 55
Sponsor: Other
Protocol IDs: ApoCell-I-IIa, NCT00524784
|
|
10.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 16 to 60
Sponsor: Other
Protocol IDs: USCTU-UR1002-GEM-TIP, UR1002-Gem-TIP, EU-20769, EUDRACT-2004-004804-19, NCT00551122
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: GIP-TG, NCT00127049
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: 4T-03-1, NCT00183820
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: MRC-TE23, EU-205107, ISRCTN53643604, EUDRACT-2004-000405-22, NCT00301782
|
|
14.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UMN-2005NT018, UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, NCT00321932
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0609-11, IUCRO-0166, AVF4003s, NCT00393861
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 10 to 69
Sponsor: NCI
Protocol IDs: UMN-2006LS032, UMN-MT2005-21, UMN-0608M90586, NCT00432094
|
|
17.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 270505-HMO-CTIL, NCT00162526
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 40
Sponsor: Other
Protocol IDs: CRCA-CCTC-ACCELERATED-BEP, CCTC-ACCELERATED-BEP, EUDRACT-2004-000847-79, EU-20713, NCT00453232
|
|
19.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: CINJ-3330, NCT00161187
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-07044, 07-044, NCT00470366
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: UMN-2007LS072, UMN-2007LS072, UMN-MT2007-07, NCT00617929
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 65 and under
Sponsor: Other
Protocol IDs: umcc 2007.137, HUM00017515, NCT00763490
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 12602, PL/ 183/UR/CEBK/04/08, EudraCT 2007-007599-40, NCT00772694
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 15 to 69
Sponsor: Other
Protocol IDs: C-005, NCT00774280
|
|
25.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08 GENH 06, NCT00864318
|
